---
title: "ATIEH MICHAEL G — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4528b265-bc53-5807-92ef-dca70e2ae0c3
json: https://whiteintel.dev/api/public/dossier/4528b265-bc53-5807-92ef-dca70e2ae0c3
identifier: sec:0001072501
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ATIEH MICHAEL G

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001072501`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4528b265-bc53-5807-92ef-dca70e2ae0c3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4528b265-bc53-5807-92ef-dca70e2ae0c3  

## Ownership & control

### Holdings / subsidiaries

- **IMMATICS B.V.** (director) — https://whiteintel.dev/entity/fe2dd7d9-8b6b-5377-8b24-c126ea302972
- **Chubb Ltd** (director) — https://whiteintel.dev/entity/7bd9cfb6-1c5a-52b4-9d17-dadc62e7419a
- **OYSTER POINT PHARMA, INC.** (director) — https://whiteintel.dev/entity/5e6eb1ea-5893-580d-adfb-09d9a3272164
- **electroCore, Inc.** (director) — https://whiteintel.dev/entity/6bb2bc2e-8d25-5651-b94e-ffcfad917064
- **IVERIC BIO, INC.** (officer) — https://whiteintel.dev/entity/38f67699-186a-55cd-83e8-7867766ff381
- **Theravance Biopharma, Inc.** (director) — https://whiteintel.dev/entity/d7255ed9-d961-59e3-906e-8f659740f843
- **ONCOGENE SCIENCE INC** (officer) — https://whiteintel.dev/entity/87a6cb55-6fc0-52bf-93b2-1ab6728f6eac

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ATIEH MICHAEL G**. Human view: https://whiteintel.dev/entity/4528b265-bc53-5807-92ef-dca70e2ae0c3 · Structured JSON: https://whiteintel.dev/api/public/dossier/4528b265-bc53-5807-92ef-dca70e2ae0c3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._